Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Catheter Precision (VTAK) Revenue (2017 - 2025)

Catheter Precision has reported Revenue over the past 9 years, most recently at $238000.0 for Q4 2025.

  • Quarterly Revenue rose 59.73% to $238000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $819000.0 through Dec 2025, up 95.0% year-over-year, with the annual reading at $819000.0 for FY2025, 95.0% up from the prior year.
  • Revenue was $238000.0 for Q4 2025 at Catheter Precision, up from $226000.0 in the prior quarter.
  • Over five years, Revenue peaked at $1.0 million in Q2 2021 and troughed at $4000.0 in Q1 2021.
  • The 5-year median for Revenue is $96000.0 (2023), against an average of $150777.8.
  • Year-over-year, Revenue crashed 99.71% in 2021 and then surged 1820.0% in 2023.
  • A 5-year view of Revenue shows it stood at $5000.0 in 2021, then changed by 0.0% to $5000.0 in 2022, then surged by 2460.0% to $128000.0 in 2023, then grew by 16.41% to $149000.0 in 2024, then skyrocketed by 59.73% to $238000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Revenue are $238000.0 (Q4 2025), $226000.0 (Q3 2025), and $212000.0 (Q2 2025).